Borregaard (BRG) Stock Overview
Engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
BRG Community Fair Values
See what 24 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Borregaard ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 144.60 |
| 52 Week High | NOK 212.00 |
| 52 Week Low | NOK 138.40 |
| Beta | 0.57 |
| 1 Month Change | -1.50% |
| 3 Month Change | -14.74% |
| 1 Year Change | -23.89% |
| 3 Year Change | -20.02% |
| 5 Year Change | -19.31% |
| Change since IPO | 598.55% |
Recent News & Updates
BRG: Dividend Support And Margin Resilience Will Underpin Future Upside
The analyst fair value estimate for Borregaard has moved from NOK 198.60 to NOK 183.80 as analysts factor in updated assumptions on revenue growth, profit margins and future P/E following recent supportive research updates from Danske Bank and Kepler Cheuvreux. Analyst Commentary Bullish Takeaways Bullish analysts highlight that recent research updates support a more constructive view on Borregaard's earnings power, which feeds directly into a higher comfort level around the updated fair value range.BRG: Dividend Support And Volume Outlook Will Underpin Future Upside
Analysts have trimmed the Borregaard fair value estimate by NOK 1.0 to NOK 198.6. This reflects slightly adjusted assumptions on discount rate, revenue growth, profit margins and future P/E following mixed recent research, including a lower price target and a downgrade alongside a separate upgrade. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the recent upgrade signals confidence that current pricing already reflects much of the previous caution baked into Borregaard's shares.Recent updates
Shareholder Returns
| BRG | NO Chemicals | NO Market | |
|---|---|---|---|
| 7D | 2.8% | -1.7% | 0.6% |
| 1Y | -23.9% | 23.6% | 18.3% |
Return vs Industry: BRG underperformed the Norwegian Chemicals industry which returned 23.6% over the past year.
Return vs Market: BRG underperformed the Norwegian Market which returned 18.3% over the past year.
Price Volatility
| BRG volatility | |
|---|---|
| BRG Average Weekly Movement | 3.9% |
| Chemicals Industry Average Movement | 7.0% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in NO Market | 11.4% |
| 10% least volatile stocks in NO Market | 3.2% |
Stable Share Price: BRG has not had significant price volatility in the past 3 months compared to the Norwegian market.
Volatility Over Time: BRG's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 1,193 | Tom Foss-Jacobsen | www.borregaard.com |
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers and biovanillin derived from lignin for agrochemicals, batteries, industrial binders, and construction, as well as to flavor and fragrance companies, and food and beverage industry.
Borregaard ASA Fundamentals Summary
| BRG fundamental statistics | |
|---|---|
| Market cap | NOK 14.45b |
| Earnings (TTM) | NOK 551.00m |
| Revenue (TTM) | NOK 7.68b |
Is BRG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BRG income statement (TTM) | |
|---|---|
| Revenue | NOK 7.68b |
| Cost of Revenue | NOK 2.71b |
| Gross Profit | NOK 4.97b |
| Other Expenses | NOK 4.42b |
| Earnings | NOK 551.00m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Jul 16, 2026
| Earnings per share (EPS) | 5.51 |
| Gross Margin | 64.71% |
| Net Profit Margin | 7.17% |
| Debt/Equity Ratio | 26.6% |
How did BRG perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/08 14:45 |
| End of Day Share Price | 2026/06/05 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Borregaard ASA is covered by 5 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Andres Castanos-Mollor | Berenberg |
| Elliott Geoffrey Jones | Danske Bank |